Traws Pharma announced a regulatory setback for its influenza program, deferring a planned Phase 2a human trial of tivoxavir marboxil (TXM) due to a negative review by the UK MHRA. Despite this, the company emphasized TXM's efficacy in animal models and its commitment to developing long-acting influenza antivirals, advancing backup candidates. Traws Pharma also confirmed a cash runway extending into Q1 2027 to support ongoing development.

Arista Networks (NYSE: ANET) stock rose over 4% on Friday following a bullish report from Morgan Stanley analyst Meta Marshall, who raised her price target to $190 from $180 while maintaining an "overweight" rating. Marshall believes Arista Networks is well-positioned to benefit as artificial intelligence (AI) implementations move into the inference stage, requiring next-generation equipment and increased processing power. The company is seen as a high-value supplier in cloud networking, poised to capitalize on the scaling of AI technologies.

General Motors (GM) is currently facing conflicting valuation views, stemming from the tension between its current cash flows, significant investments in electric vehicles, and ambitious software plans. The company's main challenge involves financing its transition to EVs and software while simultaneously protecting its traditional vehicle business. GM is categorized as a consumer stock, with its performance closely tied to consumer spending and evolving mobility needs.

Amgen is defending its rare disease drug, Tavneos, against an FDA proposal to withdraw its approval due to safety concerns and alleged clinical trial data manipulation. The pharmaceutical company has requested a hearing with the FDA and commissioned an independent review of the pivotal trial data from the Duke Clinical Research Institute. Tavneos, acquired by Amgen in 2022, treats ANCA-associated vasculitis and will remain available to patients during the review process, despite growing concerns about liver toxicity and the drug's clinical trial integrity raised during securities fraud litigation against ChemoCentryx, its original developer.

Republic Services is experiencing significant delays in trash pickup in Vienna Township, with residents reporting collections being weeks late. The article notes that visual evidence in the neighborhoods confirms these delays.

Sempra's LNG division is undergoing a change in ownership and management, which could lead to a more aggressive LNG export strategy for the California-based utility. The restructuring suggests a potential shift away from a currently risk-averse approach in its LNG ventures.

IBM is drawing renewed attention from institutional investors due to its focus on enterprise AI, cloud modernization, and quantum computing. The company's consistent dividend and resilient technology services are also contributing to its strong market presence. This increased interest highlights IBM's position as a mature technology company with robust cash flow and strategic technological advancements.

Tigo Energy director Joan C. Conley sold 50,000 shares of Common Stock at a weighted average price of $3.10 per share on June 10, 2026. The sale, executed in multiple trades ranging from $3.06 to $3.18, reduces her reported position to 227,902 shares. This remaining stake includes 33,068 shares underlying restricted stock units that are scheduled to vest prior to the company's 2027 Annual Meeting of Stockholders.

Vital Farms (VITL) stock fell by 3.64% despite overall market gains, closing at $10.60. The company projects a significant drop in its upcoming EPS and a slight decline in revenue compared to the previous year, with its Zacks Rank currently at #4 (Sell). Investors are advised to monitor analyst forecast revisions and the company's performance within the Consumer Staples sector.

Citigroup (C) has seen a 5.6% increase in its stock price following the launch of its new blockchain-based Digital Depositary Receipts and a tokenized trading platform for private-company shares. This move expands Citi's digital asset capabilities and reinforces its strategy for higher-margin fee growth, alongside ongoing liability management efforts such as redeeming 2027 debt and issuing new notes. Investors are evaluating the potential of these digital initiatives to drive future revenue and earnings against the backdrop of regulatory and transformation cost pressures.